SUBSCRIBE
SUBSCRIBE

CAR-T

Pictured: FDA sign at its office in Washington, DC/iStock, JHVEPhoto
Policy
FDA Sets Adcomm for BMS, J&J CAR T Therapies Amid Class-Wide Safety Concerns
The FDA’s Oncologic Drugs Advisory Committee will meet on March 15 to discuss BMS and J&J applications for their CAR T-cell therapies Abecma and Carvykti, respectively.
February 5, 2024
 · 
2 min read
 · 
Tristan Manalac
Drug Development
Keep calm and CAR-T on?
Lori, Greg and Tyler discuss last week’s ⁠call for a class-wide box warning⁠ on all commercial CAR T therapies, while investigations are ongoing into ⁠cases of secondary malignancies⁠. How do we approach this ⁠balancing act⁠ of treatment and side effects?
January 31, 2024
 · 
1 min read
 · 
Lori Ellis
Load More
PRESS RELEASES
Press Releases
Genezen and Optieum Biotechnologies Partner to Support cGMP Manufacturing of Groundbreaking CAR-T Therapy for Glioblastoma
May 5, 2025
 · 
3 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Second Patient Treated with HG-CT-1 CAR-T Therapy
May 2, 2025
 · 
3 min read
Press Releases
Genocury Biotech Announces Groundbreaking Advance in Relapsed/Refractory DLBCL Through Pioneering In Vivo CD19 CAR-T Therapy
May 1, 2025
 · 
4 min read
Press Releases
Capstan Therapeutics to Participate in Upcoming Scientific Conferences and Present New Preclinical Data in Support of Lead Anti-CD19 In Vivo CAR-T Candidate, CPTX2309
April 30, 2025
 · 
4 min read
Press Releases
Genocury Biotech Annouces Groundbreaking Advance in Relapsed/Refractory DLBCL Through Pioneering In Vivo CD19 CAR-T Therapy
April 30, 2025
 · 
4 min read
Press Releases
EsoBiotec to Present Preclinical Proof-of-Concept Data for Its Off-the-Shelf ENaBL In Vivo Cell Therapy Platform at the 28th Annual Meeting of the American Society of Gene and Cell Therapy
April 30, 2025
 · 
5 min read
Press Releases
Fate Therapeutics Announces Five Presentations on Off-the-Shelf CAR T-cell Product Platform at ASGCT Annual Meeting
April 30, 2025
 · 
7 min read
Press Releases
FDA Grants Breakthrough Therapy Designation for BrainChild Bio’s B7-H3 CAR T-Cell Therapy for Incurable Pediatric Brain Tumors
April 22, 2025
 · 
5 min read
Press Releases
Onward Therapeutics Announces IMPD Approval for Its Subsidiary Emercell to Start Clinical Investigation of Allogeneic NK Cell Therapy OT-C001 in Combination with Rituximab
April 22, 2025
 · 
3 min read
Press Releases
Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
April 14, 2025
 · 
3 min read
Press Releases
Cellares and University of Wisconsin School of Medicine and Public Health to Automate Clinical-Scale Production of CRISPR-Edited CAR-T for Solid Tumors
April 10, 2025
 · 
5 min read
Press Releases
Allogene Granted Three U.S. FDA Fast Track Designations (FTD) for ALLO-329, a Next-Generation Dual-Targeted CD19/CD70 Allogeneic CAR T, for the Treatment of Lupus, Myositis and Scleroderma
April 7, 2025
 · 
6 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces FDA Annual Report
April 3, 2025
 · 
3 min read
Press Releases
Everest Medicines Announces FDA Clearance of IND Application for Tumor-Associated Antigen Vaccine EVM14
March 24, 2025
 · 
9 min read
Press Releases
Wugen Announces Dosing of First Patients in Pivotal Trial of Off-the-Shelf, Allogeneic, CD7-Targeted CAR-T Cell Therapy WU-CART-007
March 20, 2025
 · 
4 min read
Press Releases
Allogenica Secures €2.5 Million Grant to Advance Universal CAR-T Therapy and Strengthen France’s Biotherapy Leadership
March 19, 2025
 · 
7 min read
Press Releases
CARsgen Announced 2024 Annual Results
March 19, 2025
 · 
9 min read
Press Releases
Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma
March 14, 2025
 · 
19 min read
Press Releases
Luminary Therapeutics to Develop Allogeneic CAR T Therapy for Targeting Solid Tumors
March 11, 2025
 · 
2 min read
Press Releases
Bioheng Therapeutics Announces FDA Clearance of IND Application for CD7 UCAR T Cell Therapy in T-ALL/LBL
March 5, 2025
 · 
2 min read
Load More